1
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
Condition(s):Refractory or Relapsed B Cell LymphomaLast Updated:March 20, 2023Not yet recruiting
B-cell Lymphoma: 3176 Clinical Trials, Page 1 of 318
Hide Studies Not Open or Pending
2
Multi-CAR-T Cells Targeting B Cell Lymphomas
Condition(s):B Cell Lymphoma (BCL)Last Updated:June 12, 2020Recruiting
3
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma – BRA-DLBCL
Condition(s):Diffuse Large B Cell LymphomaLast Updated:September 21, 2023Recruiting
4
Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
5
Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
Condition(s):B-Cell LymphomasLast Updated:November 23, 2011Completed
6
Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin’s Lymphoma
Condition(s):Diffuse Large B-cell LymphomaLast Updated:March 30, 2023Recruiting
7
Multidimensional Assessment of Quality of Life, Social and Professional Life and Care Utilization in Patients With Diffuse Large Cell B-cell Lymphoma Treated With CAR-T Cells
Condition(s):Diffuse Large B-cell Lymphoma (DLBCL); CAR-T Cells TreatmentLast Updated:September 8, 2022Not yet recruiting
8
The Study of Anti-CD19 CAR NK Cells in the Treatment of Relapsed/Refractory Diffuse Large B Cell Lymphoma
Condition(s):Diffuse Large B Cell LymphomaLast Updated:August 28, 2023Recruiting
9
Efficacy and Safety of PZ01 Treatment in Patients With r/r CD19+ B-cell Acute Lymphoblastic Leukemia/B Cell Lymphoma
Condition(s):B-cell Acute Lymphoblastic Leukemia; B-cell LymphomaLast Updated:September 15, 2017Unknown status
10
Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma
Condition(s):Relapsed or Refractory B-cell LymphomaLast Updated:August 14, 2019Unknown status